Aungst B J, Losi L L, Fung H L
Pharmacology. 1982;24(5):275-82. doi: 10.1159/000137607.
In rats, oral administration of lead-chelating resin (Chelex-100) reduced the absorption of an oral lead dose (10 mg/kg) when both doses were given at approximately the same time. The same oral resin did not reduce blood lead concentrations when administered after the lead dose had been absorbed or after systemic lead administration (1 mg/kg, intracardiac), indicating that the resin did not influence lead elimination. As a dietary supplement the resin was also ineffective in reducing blood and kidney lead concentrations in rats exposed to lead in drinking water. Thus, the possible therapeutic uses of this lead-chelating resin may be limited.
在大鼠中,当同时给予铅螯合树脂(Chelex - 100)和口服铅剂量(10毫克/千克)时,口服铅螯合树脂可降低铅的吸收。当在铅剂量已被吸收后或全身给予铅(1毫克/千克,心内注射)后给予相同的口服树脂时,并未降低血铅浓度,这表明该树脂不影响铅的消除。作为膳食补充剂,该树脂在降低饮用含铅水的大鼠的血铅和肾铅浓度方面也无效。因此,这种铅螯合树脂的可能治疗用途可能有限。